Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
Open accessThe DOI matches its Crossref record; 297 of the 302 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
HEPATITIS A IS A VACCINE-PREVENTABLE, COMMUNICABLE DISEASE OF THE LIVER CAUSED BY THE HEPATITIS A VIRUS (HAV). THE INFECTION IS TRANSMITTED VIA THE FECAL-ORAL ROUTE, USUALLY FROM DIRECT PERSON-TO-PERSON CONTACT OR CONSUMPTION OF CONTAMINATED FOOD OR WATER. HEPATITIS A IS AN ACUTE, SELF-LIMITED DISEASE THAT DOES NOT RESULT IN CHRONIC INFECTION. HAV ANTIBODIES (IMMUNOGLOBULIN G [IGG] ANTI-HAV) PRODUCED IN RESPONSE TO HAV INFECTION PERSIST FOR LIFE AND PROTECT AGAINST REINFECTION; IGG ANTI-HAV PRODUCED AFTER VACCINATION CONFER LONG-TERM IMMUNITY. THIS REPORT SUPPLANTS AND SUMMARIZES PREVIOUSLY PUBLISHED RECOMMENDATIONS FROM THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) REGARDING THE PREVENTION OF HAV INFECTION IN THE UNITED STATES. ACIP RECOMMENDS ROUTINE VACCINATION OF CHILDREN AGED 12-23 MONTHS AND CATCH-UP VACCINATION FOR CHILDREN AND ADOLESCENTS AGED 2-18 YEARS WHO HAVE NOT PREVIOUSLY RECEIVED HEPATITIS A (HEPA) VACCINE AT ANY AGE. ACIP RECOMMENDS HEPA VACCINATION FOR ADULTS AT RISK FOR HAV INFECTION OR SEVERE DISEASE FROM HAV INFECTION AND FOR ADULTS REQUESTING PROTECTION AGAINST HAV WITHOUT ACKNOWLEDGMENT OF A RISK FACTOR. THESE RECOMMENDATIONS ALSO PROVIDE GUIDANCE FOR VACCINATION BEFORE TRAVEL, FOR POSTEXPOSURE PROPHYLAXIS, IN SETTINGS PROVIDING SERVICES TO ADULTS, AND DURING OUTBREAKS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By 1 month after the first dose, 94%–100% of adults have protective antibody levels, and after a second dose, 100% achieve protective levels (1297,1300,1301).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1297]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Antibody produced in response to HAV infection persists for life and confers protection against reinfection (1297).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1297]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
(1999) · PsycEXTRA Dataset · doi:10.1037/e547812006-001 · Cited by 1,131
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit816 · Cited by 1,037
Schillie, S., Vellozzi, C., Reingold, A., Harris, A., Haber, P., Ward, J. W., & Nelson, N. P. (2018) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6701a1 · Cited by 815
Self-citationShefer, A. M., & Atkinson, W. W. (2011) · Cited by 666
ICTV Virus Taxonomy Profile: Picornaviridae
Zell, R., Delwart, E., Gorbalenya, A. E., Hovi, T., King, A. M. Q., Knowles, N. J., Lindberg, A. M., Pallansch, M. A., Palmenberg, A. C., Reuter, G., et al. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000911 · Cited by 631
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & DeStefano, F. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 608
McLean, H. Q., Fiebelkorn, A. P., Temte, J. L., & Wallace, G. S. (2013) · PubMed · Cited by 607
A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children
Werzberger, A., Mensch, B., Kuter, B., Brown, L., Lewis, J., Sitrin, R., Miller, W., Shouval, D., Wiens, B., Calandra, G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208133270702 · Cited by 540
Genetic relatedness of hepatitis A virus strains recovered from different geographical regions
Robertson, B. H., Jansen, R. W., Khanna, B., Totsuka, A., Nainan, O. V., Siegl, G., Widell, A., Margolis, H. S., Isomura, S., Ito, K., et al. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-6-1365 · Cited by 495
Drug Use and Dependence, State and Federal Prisoners, 2004: (560272006-001)
Mumola, C. J., & Karberg, J. C. (2006) · PsycEXTRA Dataset · doi:10.1037/e560272006-001 · Cited by 480
Surveillance of vaccination coverage among adult populations—United States, 2015.
Williams, W. W., Lu, P.-J., O’Halloran, A., Kim, D. K., Grohskopf, L. A., Pilishvili, T., Skoff, T. H., Nelson, N. P., Harpaz, R., Markowitz, L. E., et al. (2017) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6611a1 · Cited by 442
Self-citation(2011) · PubMed · Cited by 424
Protection Against Hepatitis A by an Inactivated Vaccine
Innis, B. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510410040030 · Cited by 417
Outness, Stigma, and Primary Health Care Utilization among Rural LGBT Populations
Whitehead, J., Shaver, J., & Stephenson, R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146139 · Cited by 407
Zhou, W., Pool, V., Iskander, J. K., English-Bullard, R., Ball, R., Wise, R. P., Haber, P., Pless, R., Mootrey, G. T., Ellenberg, S. S., et al. (2003) · PubMed · Cited by 400
Self-citationAn Outbreak of Hepatitis A Associated with Green Onions
Dentinger, C. M., Bower, W. A., Nainan, O. V., Cotter, S. M., Myers, G., Dubusky, L. M., Fowler, S., Salehi, E. D. P., & Bell, B. P. (2001) · The Journal of Infectious Diseases · doi:10.1086/319688 · Cited by 395
Diagnosis of Hepatitis A Virus Infection: a Molecular Approach
Nainan, O. V., Xia, G., Vaughan, G., & Margolis, H. S. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.63-79.2006 · Cited by 395
A Multistate, Foodborne Outbreak of Hepatitis A
Hutin, Y. J. F., Pool, V., Cramer, E. H., Nainan, O. V., Weth, J., Williams, I. T., Goldstein, S. T., Gensheimer, K. F., Bell, B. P., Shapiro, C. N., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902253400802 · Cited by 387
Hepatitis A Transmitted by Food
Fiore, A. E. (2004) · Clinical Infectious Diseases · doi:10.1086/381671 · Cited by 352 · cited 2×
“Infection with HAV has not been found to cause chronic infection, although prolonged or relapsing hepatitis A has been reported (5).”
BackgroundViral hepatitis. New light on an old disease
Krugman, S. (1970) · JAMA · doi:10.1001/jama.212.6.1019 · Cited by 348
FREQUENCY OF ILLNESS ASSOCIATED WITH EPIDEMIC HEPATITIS A VIRUS INFECTIONS IN ADULTS
LEDNAR, W. M., LEMON, S. M., KIRKPATRICK, J. W., REDFIELD, R. R., FIELDS, M. L., & KELLEY, P. W. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114093 · Cited by 343
Type A Viral Hepatitis: New Developments in an Old Disease
Lemon, S. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510243131706 · Cited by 338
Lemon, S. M., Ott, J. J., Van Damme, P., & Shouval, D. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.034 · Cited by 336
Viral Hepatitis in HIV Infection
Koziel, M. J., & Peters, M. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmra065142 · Cited by 322
An Outbreak of Hepatitis A Associated with Green Onions
Wheeler, C., Vogt, T. M., Armstrong, G. L., Vaughan, G., Weltman, A., Nainan, O. V., Dato, V., Xia, G., Waller, K., Amon, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050855 · Cited by 311
Hepatitis A in Day-Care Centers: A Community-Wide Assessment
Hadler, S. C., Webster, H. M., Erben, J. J., Swanson, J. E., & Maynard, J. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005293022203 · Cited by 300
Hepatitis A Virus: From Discovery to Vaccines
Martin, A., & Lemon, S. M. (2006) · Hepatology · doi:10.1002/hep.21052 · Cited by 299
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
Keeffe, E. B., Iwarson, S., McMahon, B. J., Lindsay, K. L., Koff, R. S., Manns, M., Baumgarten, R., Wiese, M., Fourneau, M., Safary, A., et al. (1998) · Hepatology · doi:10.1002/hep.510270336 · Cited by 268
Koff, R. S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01304-x · Cited by 265
The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety
McNeil, M. M., Gee, J., Weintraub, E. S., Belongia, E. A., Lee, G. M., Glanz, J. M., Nordin, J. D., Klein, N. P., Baxter, R., Naleway, A. L., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.073 · Cited by 247
Mannucci, P. M., Gdovin, S., Gringeri, A., Colombo, M., Mele, A., Schinaia, N., Ciavarella, N., Emerson, S. U., Purcell, R. H., & and Italian Collaborative Group* (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00001 · Cited by 241
Multistate Outbreak of Hepatitis A Associated with Frozen Strawberries
Niu, M. T., Polish, L. B., Robertson, B. H., Khanna, B. K., Woodruff, B. A., Shapiro, C. N., Miller, M. A., Smith, J. D., Gedrose, J. K., Alter, M. J., et al. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.3.518 · Cited by 239
Hepatitis A booster vaccination: is there a need?
Van Damme, P., Banatvala, J., Fay, O., Iwarson, S., McMahon, B., Van Herck, K., Shouval, D., Bonanni, P., Connor, B., Cooksley, G., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14418-2 · Cited by 238
Duration of viremia in hepatitis A virus infection.
Bower, W. A., Nainan, O. V., Han, X., & Margolis, H. S. (2000) · The Journal of Infectious Diseases · doi:10.1086/315701 · Cited by 232
Bell, B. P., Shapiro, C. N., Alter, M. J., Moyer, L. A., Judson, F. N., Mottram, K., Fleenor, M., Ryder, P. L., & Margolis, H. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/314518 · Cited by 225
Clinical experience with an inactivated hepatitis A vaccine.
Clemens, R., Safary, A., Hepburn, A., Roche, C., Stanbury, W. J., & Andre, F. E. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s44 · Cited by 223
Relapsing Hepatitis A Review of 14 Cases and Literature Survey
Glikson, M., Galun, E., Oren, R., Tur-Kaspa, R., & Shouval, D. (1992) · MEDICINE · doi:10.1097/00005792-199201000-00002 · Cited by 216
Viral Hepatitis: New Light on an Old Disease
Krugman, S. (1970) · JAMA · doi:10.1001/jama.1970.03170190035005 · Cited by 216
A multifocal outbreak of hepatitis A traced to commercially distributed lettuce.
Rosenblum, L. S., Mirkin, I. R., Allen, D. T., Safford, S., & Hadler, S. C. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.9.1075 · Cited by 211
A multistate outbreak of hepatitis A caused by the consumption of raw oysters.
Desenclos, J. C., Klontz, K. C., Wilder, M. H., Nainan, O. V., Margolis, H. S., & Gunn, R. A. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.10.1268 · Cited by 197
Ndumbi, P., Freidl, G. S., Williams, C. J., Mårdh, O., Varela, C., Avellón, A., Friesema, I., Vennema, H., Beebeejaun, K., Ngui, S. L., et al. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.33.1700641 · Cited by 194
Clinical manifestations and diagnosis of hepatitis A virus infection
Koff, R. S. (1992) · Vaccine · doi:10.1016/0264-410x(92)90533-p · Cited by 188
Globalization and the Changing Epidemiology of Hepatitis A Virus
Jacobsen, K. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031716 · Cited by 184
Rosenblum, L. S., Villarino, M. E., Nainan, O. V., Melish, M. E., Hadler, S. C., Pinsky, P. P., Jarvis, W. R., Ott, C. E., & Margolis, H. S. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.3.476 · Cited by 182
Epidemiology and Prevention of Hepatitis A in Travelers
Steffen, R. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520110065031 · Cited by 182
Clinical Manifestations Of Hepatitis A: Recent Experience In A Community Teaching Hospital
Tong, M. J., El-Farra, N. S., & Grew, M. I. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s15 · Cited by 181
Substance use and homelessness among emergency department patients
Doran, K. M., Rahai, N., McCormack, R. P., Milian, J., Shelley, D., Rotrosen, J., & Gelberg, L. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.021 · Cited by 172
Hepatitis A Virus in Stool During Clinical Relapse
SJOGREN, M. H., TANNO, H., FAY, O., SILEONI, S., COHEN, B. D., BURKE, D. S., & FEIGHNY, R. J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-221 · Cited by 171
Hepatitis A virus: Host interactions, molecular epidemiology and evolution
Vaughan, G., Goncalves Rossi, L. M., Forbi, J. C., de Paula, V. S., Purdy, M. A., Xia, G., & Khudyakov, Y. E. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.10.023 · Cited by 167
Genetic variability of hepatitis A virus
Costa-Mattioli, M., Napoli, A. D., Ferré, V., Billaudel, S., Perez-Bercoff, R., & Cristina, J. (2003) · Journal of General Virology · doi:10.1099/vir.0.19532-0 · Cited by 164
McMahon, B. J. (1996) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1996.02170320079014 · Cited by 163
Frozen raspberries and hepatitis A
Reid, T. M. S., & Robinson, H. G. (1987) · Epidemiology and Infection · doi:10.1017/s095026880006177x · Cited by 161
Posttransfusion Hepatitis A in a Neonatal Intensive Care Unit
Noble, R. C. (1984) · JAMA · doi:10.1001/jama.1984.03350190013011 · Cited by 144 · cited 2×
“HepA vaccine should be integrated into routine preventive services for persons experiencing homelessness (15).”
BackgroundNeilsen, G. A., Bodsworth, N., & Watts, N. (1997) · The Journal of Infectious Diseases · doi:10.1086/516512 · Cited by 143
Survival of hepatitis A virus in feces after drying and storage for 1 month
McCaustland, K. A., Bond, W. W., Bradley, D. W., Ebert, J. W., & Maynard, J. E. (1982) · Journal of Clinical Microbiology · doi:10.1128/jcm.16.5.957-958.1982 · Cited by 140
DAGAN, R., AMIR, J., MIJALOVSKY, A., KALMANOVITCH, I., BAR-YOCHAI, A., THOELEN, S., SAFARY, A., & ASHKENAZI, S. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200011000-00004 · Cited by 140
Serum Neutralizing Antibody Response to Hepatitis A Virus
Lemon, S. M., & Binn, L. N. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/148.6.1033 · Cited by 140
Staes, C. J., SCHLENKER, T. L., Risk, I., Cannon, K. G., Harris, H., Pavia, A. T., Shapiro, C. N., & Bell, B. P. (2000) · PEDIATRICS · doi:10.1542/peds.106.4.e54 · Cited by 138 · cited 3×
“, ≥10 but <20 cases per 100,000 population) (7).”
BackgroundImmunoglobulin prophylaxis for hepatitis A.
Winokur, P. L., & Stapleton, J. T. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.580 · Cited by 136
Collier, M. G., Khudyakov, Y. E., Selvage, D., Adams-Cameron, M., Epson, E. E., Cronquist, A., Jervis, R. H., Lamba, K., Kimura, A. C., Sowadsky, R., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70883-7 · Cited by 133
Self-citationHost Immune Response To Hepatitis A Virus
Stapleton, J. T. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s9 · Cited by 129
Serres, G. D., Cromeans, T. L., Lévesque, B., Brassard, N., Barthe, C., Dionne, M., Prud'homme, H., Paradis, D., Shapiro, C. N., Nainan, O. V., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314565 · Cited by 126
Influence of Human Immunodeficiency Virus Type 1 Infection on Acute Hepatitis A Virus Infection
Sachiko, I. D. A., Tachikawa, N., Nakajima, A., Daikoku, M., Yano, M., Kikuchi, Y., Yasuoka, A., Kimura, S., & Oka, S. (2002) · Clinical Infectious Diseases · doi:10.1086/338152 · Cited by 125
Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus
Laurence, J. C. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.024 · Cited by 124
The Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A†
Kao, H. W., Ashcavai, M., & Redeker, A. G. (1984) · Hepatology · doi:10.1002/hep.1840040525 · Cited by 124
Increase in hepatitis A virus infections—United States, 2013–2018.
Foster, M. A., Hofmeister, M. G., Kupronis, B. A., Lin, Y., Xia, G.-L., Yin, S., & Teshale, E. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6818a2 · Cited by 123
Self-citationFoster, M., Ramachandran, S., Myatt, K., Donovan, D., Bohm, S., Fiedler, J., Barbeau, B., Collins, J., Thoroughman, D., McDonald, E., et al. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6743a3 · Cited by 123
Hepatitis vaccination in patients with chronic liver disease
Reiss, G. M., & Keeffe, E. B. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01906.x · Cited by 121
Hepatitis A virus infections associated with clotting factor concentrate in the United States
Soucie, J. M., Robertson, B. H., Bell, B. P., McCaustland, K. A., & Evatt, B. L. (1998) · Transfusion · doi:10.1046/j.1537-2995.1998.38698326337.x · Cited by 117
van Schaik, S. M., Obot, N., Enhörning, G., Hintz, K. H., Gross, K. J., Hancock, G. E., Stack, A. M., & Welliver, C. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200010)62:2<144::aid-jmv4>3.0.co;2-i · Cited by 117
Kemper, C. A., Haubrich, R., Frank, I., Dubin, G., Buscarino, C., McCutchan, J. A., Deresinski, S. C., & California Collaborative Treatment Group (2003) · The Journal of Infectious Diseases · doi:10.1086/374562 · Cited by 117
Challenges to mapping the health risk of hepatitis A virus infection
Hanafiah, K. M., Jacobsen, K. H., & Wiersma, S. (2011) · International Journal of Health Geographics · doi:10.1186/1476-072x-10-57 · Cited by 113
SAFETY AND EFFICACY OF HEPATITIS A VACCINATION IN LIVER TRANSPLANTATION RECIPIENTS1, 2
Arslan, M., Wiesner, R. H., Poterucha, J. J., & Zein, N. N. (2001) · Transplantation · doi:10.1097/00007890-200107270-00019 · Cited by 112
Lin, K., Chen, G., Lee, Y.-L., Huang, Y., Cheng, A., Sun, H., Chang, S., Liu, C.-E., & Hung, C. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i20.3589 · Cited by 112
RAPID DECLINE OF ANTIBODIES AFTER HEPATITIS A IMMUNIZATION IN LIVER AND RENAL TRANSPLANT RECIPIENTS
Günther, M., Stark, K., Neuhaus, R., Reinke, P., Schröder, K., & Bienzle, U. (2001) · Transplantation · doi:10.1097/00007890-200102150-00023 · Cited by 111
Immunogenicity and Safety of Hepatitis A Vaccine in Liver and Renal Transplant Recipients
Stark, K., Günther, M., Neuhaus, R., Reinke, P., Schröder, K., Linnig, S., & Bienzle, U. (1999) · The Journal of Infectious Diseases · doi:10.1086/315125 · Cited by 111
Joines, R. W., Blatter, M. M., Abraham, B., Xie, F., Clercq, N. D., Baine, Y., Reisinger, K. S., Kuhnen, A. E., & Parenti, D. L. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00240-7 · Cited by 110
Diagnosis of hepatitis a and b by testing saliva
Parry, J. V., Perry, K. R., Mortimer, P. P., & Panday, S. (1989) · Journal of Medical Virology · doi:10.1002/jmv.1890280410 · Cited by 109
Safety and Immunogenicity of an Inactivated Hepatitis A Vaccine among HIV-Infected Subjects
Wallace, M. R., Brandt, C. J., Earhart, K. C., Kuter, B. J., Grosso, A. D., Lakkis, H. D., & Tasker, S. A. (2004) · Clinical Infectious Diseases · doi:10.1086/424666 · Cited by 105
Immunogenicity of hepatitis A vaccine in decompensated liver disease
Dumot, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00206-3 · Cited by 104
Protection against hepatitis A by an inactivated vaccine.
Innis, B. L., Snitbhan, R., Kunasol, P., et al. (1994) · PubMed · Cited by 104
The role of young children in a community-wide outbreak of hepatitis A
Smith, P. F., Grabau, J. C., Werzberger, A., Gunn, R. A., Rolka, H., Kondracki, S. F., Gallo, R. J., & Morse, D. L. (1997) · Epidemiology and Infection · doi:10.1017/s0950268897007462 · Cited by 100
Vaccination in HIV-Infected Adults
Crum‐Cianflone, N. F., & Wallace, M. R. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0121 · Cited by 100
Cohen, J. I., Feinstone, S., & Purcell, R. H. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/160.5.887 · Cited by 98
Cotter, S. M., Sansom, S. L., Long, T., Koch, E., Kellerman, S., Smith, F., Averhoff, F. M., & Bell, B. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/374057 · Cited by 96
Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants
Letson, G. W., Shapiro, C. N., Kuehn, D., Gardea, C., Welty, T. K., Krause, D. S., Lambert, S. B., & Margolis, H. S. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.11.030 · Cited by 96
Hill, H. A., Singleton, J. A., Yankey, D., Elam–Evans, L. D., Pingali, C., & Kang, Y. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6841e2 · Cited by 96
McMahon, B. J., Williams, J. L., BULKOW, L. R., Snowball, M. M., Wainwright, R. B., Kennedy, M., & Krause, D. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.3.676 · Cited by 94
Nelson, N. P., Link‐Gelles, R., Hofmeister, M. G., Romero, J. R., Moore, K. L., Ward, J. W., & Schillie, S. F. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6743a5 · Cited by 92 · cited 6×
“In children aged <6 years, 70% of infections are asymptomatic; illnesses that do occur are not typically accompanied by jaundice (1,51).”
BackgroundInfluentialSelf-citationNainan, O. V., Armstrong, G. L., Han, X., Williams, I., Bell, B. P., & Margolis, H. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/427992 · Cited by 91
Bloch, A. B., Stramer, S. L., SMITH, J., Margolis, H. S., Fields, H. A., Tw, M., Gerba, C. P., Maynard, J. E., & Sikes, R. K. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.4.428 · Cited by 88
Yotsuyanagi, H. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008707246 · Cited by 88
Weinberg, A., Gona, P. N., Nachman, S., Defechereux, P. A., Yogev, R., Hughes, W., Wara, D. W., Spector, S. A., Read, J. S., Elgie, C., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/498979 · Cited by 88
Properties and classification of hepatitis A virus
Melnick, J. L. (1992) · Vaccine · doi:10.1016/0264-410x(92)90536-s · Cited by 87
Hepatitis B and A vaccination in HIV-infected adults: A review
Mena, G., García‐Basteiro, A. L., & Bayas, J. M. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1055424 · Cited by 87
Risk Factors for Hepatitis A in Day-Care Centers
Hadler, S. C., Erben, J. J., Francis, D. P., Webster, H., & Maynard, J. E. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/145.2.255 · Cited by 87
A new accelerated vaccination schedule for rapid protection against hepatitis A and B
Nothdurft, H. D., Dietrich, M., Zuckerman, J. N., Knobloch, J., Kern, P., Vollmar, J., & Sänger, R. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00432-7 · Cited by 86
André, F., Damme, P. V., Safary, A., & Banatvala, J. E. (2002) · Expert Review of Vaccines · doi:10.1586/14760584.1.1.9 · Cited by 84
Yotsuyanagi, H., Koike, K., Yasuda, K., et al. (1996) · Hepatology · doi:10.1002/hep.510240103 · Cited by 84
Production, quality control and characterization of an inactivated hepatitis A vaccine
Peetermans, J. (1992) · Vaccine · doi:10.1016/0264-410x(92)90557-z · Cited by 83
Theeten, H., Van Herck, K., Van Der Meeren, O., Crasta, P., Van Damme, P., & Hens, N. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.008 · Cited by 82
The Burden of Liver Disease in Human Immunodeficiency Virus-Infected Patients
Puoti, M., Moioli, M., Travi, G., & Rossotti, R. (2012) · Seminars in Liver Disease · doi:10.1055/s-0032-1316473 · Cited by 82
Multiple Modes of Hepatitis A Virus Transmission among Methamphetamine Users
Hutin, Y. J. F., Sabin, K. M., Hutwagner, L. C., Schaben, L., Shipp, G. M., Lord, D. M., Conner, J. S., Quinlisk, M. P., Shapiro, C. N., & Bell, B. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.2.186 · Cited by 80
Stapleton, J. T., Jansen, R. W., & Lemon, S. M. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90462-7 · Cited by 80
An Outbreak of Hepatitis A Associated with Swimming in a Public Pool
Mahoney, F. J., Farley, T. A., KELSO, K. Y., Wilson, S. A., Horan, J. M., & McFarland, L. M. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.4.613 · Cited by 79
Kemmer, N. M., & Miskovsky, E. P. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70123-9 · Cited by 79
Reuman, P. D., Kubilis, P. S., Hurni, W. M., Brown, L., & Nalin, D. R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00310-6 · Cited by 78
Predictors of immunity after hepatitis A vaccination in HIV‐infected persons
Overton, E. T., Nurutdinova, D., D, S. S. M., Seyfried, W., Groger, R. K., & Powderly, W. G. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2006.00822.x · Cited by 78
Lemon, S. M. (1994) · Vox Sanguinis · doi:10.1111/j.1423-0410.1994.tb01293.x · Cited by 78
Molecular Epidemiology of Foodborne Hepatitis A Outbreaks in the United States, 2003
Amon, J. J., Devasia, R. A., Xia, G., Nainan, O. V., Hall, S., Lawson, B. M., Wolthuis, J. S., MacDonald, P. D. M., Shepard, C. W., Williams, I. T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/462425 · Cited by 78
Tassopoulos, N., PAPAEVANGELOU, G. J., Ticehurst, J. R., & Purcell, R. H. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/154.2.231 · Cited by 77
Safety and immunogenicity of hepatitis A vaccine in healthy children
Horng, Y.-C., Chang, M., Lee, C., Safary, A., ANDRE, F. E., & Chen, D. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199305000-00001 · Cited by 77
What did we learn from the Shanghai hepatitis A epidemic?
Cooksley, W. G. E. (2000) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2000.00021.x · Cited by 77
Klein, B. S. (1984) · JAMA · doi:10.1001/jama.252.19.2716 · Cited by 76
Shouval, D., Ashur, Y., Adler, R., Lewis, J. A., Armstrong, M. E., Davide, J. P., McGuire, B., Kuter, B. J., Brown, L., Miller, W. J. W., et al. (1993) · Vaccine · doi:10.1016/0264-410x(93)90151-m · Cited by 76
Doshani, M., Weng, M., Moore, K. L., Romero, J. R., & Nelson, N. P. (2019) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6806a6 · Cited by 75
Self-citationCost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States
Rein, D. B., Hicks, K. A., Wirth, K. E., Billah, K., Finelli, L., Fiore, A. E., Hoerger, T. J., Bell, B. P., & Armstrong, G. L. (2007) · PEDIATRICS · doi:10.1542/peds.2006-1573 · Cited by 75
An outbreak of hepatitis A among health care workers: risk factors for transmission.
Doebbeling, B. N., Li, N., & Wenzel, R. P. (1993) · American Journal of Public Health · doi:10.2105/ajph.83.12.1679 · Cited by 75
The Antibody Response Following Hepatitis A Infection
LOCARNINI, S. A., Ferris, A. A., Lehmann, N. I., & Gust, I. D. (1977) · Intervirology · doi:10.1159/000148905 · Cited by 74
Fiore, A. E., Shapiro, C. N., Sabin, K. M., LABONTE, K., Darling, K., Culver, D. H., Bell, B. P., & Margolis, H. S. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000059446.52063.b9 · Cited by 74
Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA
Cohen, J. I., Rosenblum, B., Feinstone, S. M., Ticehurst, J. R., & Purcell, R. H. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5364-5370.1989 · Cited by 73
Comparison of immunogenicity of two hepatitis A vaccines — VAQTA® and HAVRIX® — in young adults
Ashur, Y., Adler, R., Rowe, M., & Shouval, D. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00480-0 · Cited by 73
Ott, J. J., & Wiersma, S. T. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.04.012 · Cited by 71
Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells
Funkhouser, A. W., Purcell, R. H., d'Hondt, E., & Emerson, S. U. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.148-157.1994 · Cited by 69
Response to hepatitis A vaccine in HIV‐positive patients1
Weissman, S., Feucht, C. L., & Moore, B. A. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00658.x · Cited by 69
Piazza, M., Safary, A., Vegnente, A., Soncini, R., Pensati, P., Sardo, M., Orlando, R., Tosone, G., & Picciotto, L. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00237-0 · Cited by 69
Hepatitis A Outbreak Associated With Green Onions at a Restaurant—Monaca, Pennsylvania, 2003
(2003) · JAMA · doi:10.1001/jama.290.24.3187 · Cited by 69
Liaw, Y., Yang, C., Chu, C., & Huang, M. J. (1986) · Infection · doi:10.1007/bf01645253 · Cited by 68
Immunogenicity of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Bell, B. P., Negus, S., Fiore, A. E., Plotnik, J., Dhotre, K. B., Williams, J., Shapiro, C. N., & McMahon, B. J. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000253253.85640.cc · Cited by 68
Long-term Durability of Immune Responses After Hepatitis A Vaccination Among HIV-Infected Adults
Crum‐Cianflone, N. F., Wilkins, K. J., Lee, A. W.-T., Grosso, A. D., Landrum, M. L., Weintrob, A., Ganesan, A., Maguire, J. D., Klopfer, S. O., Brandt, C., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir180 · Cited by 68
Regan, D. G., Wood, J., BENEVENT, C., Ali, H., SMITH, L. W., Robertson, P. W., Ferson, M. J., Fairley, C. K., Donovan, B. J., & Law, M. G. (2015) · Epidemiology and Infection · doi:10.1017/s0950268815002605 · Cited by 67
collective Nordic outbreak investigation team (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.27.20520 · Cited by 67
Bríem, H., & Safary, A. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440424 · Cited by 66
Armstrong, M. E., Giesa, P. A., Davide, J. P., Redner, F., Waterbury, J. A., Rhoad, A. E., Keys, R. D., PROVOST, P. J., & Lewis, J. A. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80373-3 · Cited by 66
Hens, N., Habteab Ghebretinsae, A., Hardt, K., Van Damme, P., & Van Herck, K. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.10.088 · Cited by 65
A COMMUNITY-WIDE EPIDEMIC OF HEPATITIS A IN OHIO
Shaw, F. E., Sudman, J., Smith, S. M., WILLIAMS, D. L., KAPELL, L. A., Hadler, S. C., Halpin, T. J., & Maynard, J. E. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114334 · Cited by 63
Robertson, B. H. (2001) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2001.00295.x · Cited by 63
High and persistent excretion of hepatitis A virus in immunocompetent patients
Tjon, G., Coutinho, R. A., van den Hoek, A., Esman, S., Wijkmans, C. J., Hoebe, C. J. P. A., Wolters, B., Swaan, C. M., Geskus, R. B., Dukers–Muijrers, N. H. T. M., et al. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20711 · Cited by 63
Vento, S. (2000) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2000.00019.x · Cited by 62
Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines
Bryan, J. P., Henry, C. H., Hoffman, A. G., South-Paul, J. E., Smith, J. A., Cruess, D. F., Spieker, J., & de Medina, M. D. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00301-7 · Cited by 59
Safety And Immunogenicity Of An Inactivated Hepatitis A Vaccine In Preschool Children
Balcarek, K. B., Bagley, M. R., Pass, R. F., Schiff, E. R., & Krause, D. S. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s70 · Cited by 59
Homelessness and Hepatitis A—San Diego County, 2016–2018
Peak, C. M., Stous, S., Healy, J. M., Hofmeister, M. G., Lin, Y., Ramachandran, S., Foster, M. A., Kao, A. S., & McDonald, E. C. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz788 · Cited by 59
Self-citationHepatitis A hospitalizations in the United States, 2002‐2011
Collier, M. G., Tong, X., & Xu, F. (2014) · Hepatology · doi:10.1002/hep.27537 · Cited by 58
Troisi, C. L., Hollinger, F. B., Krause, D. S., & Pickering, L. K. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00199-0 · Cited by 57
Response to hepatitis A vaccine in HIV patients in the HAART era
Rimland, D., & Guest, J. L. (2005) · AIDS · doi:10.1097/01.aids.0000186815.99993.55 · Cited by 57
Czeschinski, P. A. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00354-0 · Cited by 57
Rivas, V., Barrera, A., Pino, K., Núñez, R., Cáceres, C. J., López‐Lastra, M., & Soza, A. (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.9.18-00060 · Cited by 57
Response to Hepatitis A Vaccination in Immunocompromised Travelers
Garrido, H. M. G., Wieten, R. W., Grobusch, M. P., & Goorhuis, A. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv060 · Cited by 56
Simultaneous vaccination against hepatitis A and B: results of a controlled study
Ambrosch, F., André, F. E., Delem, A., D'Hondt, E., Jonas, S., Kunz, C., Safary, A., & Wiedermann, G. (1992) · Vaccine · doi:10.1016/0264-410x(92)90570-a · Cited by 56
Prolonged hepatitis A infection in an HIV‐1 seropositive patient
Costa‐Mattioli, M., Allavena, C., Poirier-Toulemonde, A.-S., Billaudel, S., Raffi, F., & Ferré, V. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10163 · Cited by 56
Wagner, G., Lavanchy, D., Darioli, R., Pécoud, A. R., Brulein, V., Safary, A., & Frei, P. C. (1993) · Vaccine · doi:10.1016/0264-410x(93)90128-k · Cited by 54
Sheth, A. N., Moore, R. D., & Gebo, K. A. (2006) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.20.318 · Cited by 54
Moro, P. L., Museru, O., Niu, M. T., Lewis, P., & Broder, K. R. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.12.036 · Cited by 54
Lemon, S. M., Murphy, P. C., PROVOST, P. J., Chalikonda, I., Davide, J. P., Schofield, T. L., Nalin, D. R., & Lewis, J. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/514044 · Cited by 53
(2004) · PsycEXTRA Dataset · doi:10.1037/e548642006-001 · Cited by 53
Fulminant Hepatitis A in Patients with Chronic Liver Disease
Lefilliatre, P., & Villeneuve, J. (2000) · Canadian Journal of Public Health · doi:10.1007/bf03404264 · Cited by 52
Immunologic approaches to assessing the response to inactivated hepatitis A vaccine
Lemon, S. M. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80372-1 · Cited by 52
Detection of Hepatitis A Virus RNA in Saliva
Mackiewicz, V., Dussaix, É., Petitcorps, M.-F. L., & Roque‐Afonso, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4329-4331.2004 · Cited by 51
Gozlan, Y., Bar-Or, I., Rakovsky, A., Savion, M., Amitai, Z., Sheffer, R., Ceder, N., Anis, E., Grotto, I., Mendelson, E., et al. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.29.30575 · Cited by 51
Pathogen inactivation and removal methods for plasma‐derived clotting factor concentrates
Klamroth, R., Gröner, A., & Simon, T. L. (2013) · Transfusion · doi:10.1111/trf.12423 · Cited by 50
Immunogenicity and Safety of Hepatitis A Vaccine in Children With Chronic Liver Disease
Ferreira, C. T., da Silveira, T. R., Vieira, S. M. G., Taniguchi, A. N. R., & Pereira‐Lima, J. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200309000-00011 · Cited by 50
Occurrence of Acute Hepatitis A in Patients Infected with Human Immunodeficiency Virus
Fonquernie, L., Meynard, J., Charrois, A., Delamare, C., Meyohas, M., & Frottier, J. (2001) · Clinical Infectious Diseases · doi:10.1086/318478 · Cited by 50
Occupations at Increased Risk of Hepatitis A: A 2-Year Nationwide Historical Prospective Study
Lerman, Y., Chodick, G., Aloni, H., Ribak, J., & Ashkenazi, S. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010004 · Cited by 49
Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study
Groom, H. C., Irving, S. A., Koppolu, P., Smith, N. X., Vazquez‐Benitez, G., Kharbanda, E. O., Daley, M. F., Donahue, J. G., Getahun, D., Jackson, L. A., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.074 · Cited by 49
Iwarson, S. A., Lindh, M., & Widerström, L. (2006) · Journal of Travel Medicine · doi:10.2310/7060.2004.17079 · Cited by 48
Antibody to Hepatitis A Antigen in Institutionalized Mentally Retarded Patients
Szmuness, W. (1977) · JAMA · doi:10.1001/jama.1977.03270430044016 · Cited by 47
Evaluation of Occupational Transmission of Hepatitis A Virus Among Wastewater Workers
Trout, D. B., Mueller, C., Venczel, L., & Krake, A. M. (2000) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200001000-00020 · Cited by 47
Victor, J. C., Surdina, T. Y., Suleimenova, S. Z., Favorov, M. O., Bell, B. P., & Monto, A. S. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwj029 · Cited by 47 · cited 6×
“In 1996, the Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination of children aged ≥2 years who lived in communities with high rates of HAV infection, for populations at increased risk for HAV infection or the adverse consequences of infection, and in outbreak settings (6).”
BackgroundInfluentialImpact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil
Souto, F. J. D., de Brito, W. I., & Fontes, C. J. F. (2019) · Vaccine · doi:10.1016/j.vaccine.2018.12.054 · Cited by 47
Susceptibility to hepatitis A virus infection in the United States, 2007–2016.
Yin, S., Barker, L., Ly, K. N., Kilmer, G., Foster, M. A., Drobeniuc, J., & Jiles, R. B. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa298 · Cited by 46
Williams, J. L., Bruden, D. J. T., Cagle, H. H., McMahon, B. J., Negus, S. E., Christensen, C. J., Snowball, M. M., BULKOW, L. R., & Fox-Leyva, L. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00250-0 · Cited by 46
Nosocomial hepatitis A infection in a paediatric intensive care unit.
Drusin, L. M., Sohmer, M., Groshen, S. L., Spiritos, M. D., SENTERFIT, L. B., & Christenson, W. N. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.7.690 · Cited by 46 · cited 1×
“Vaccine safety hypotheses can be generated, but not assessed, through VAERS and are subject to limitations including reporting biases and inconsistent data quality (18,19).”
BackgroundTseng, Y.-T., Chang, S., Liu, W., Sun, H., Wu, C.-H., Wu, P., Lu, C.-L., Hung, C., & Chang, S. (2012) · Hepatology · doi:10.1002/hep.26210 · Cited by 45
Kinetics of maternal hepatitis a antibody decay in infants: implications for vaccine use
Lieberman, J. M., Chang, S., Partridge, S., Hollister, J. C., Kaplan, K. M., Jensen, E. H., Kuter, B. J., & Ward, J. I. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200204000-00017 · Cited by 45
Latash, J., Dorsinville, M. S., Rosso, P. D., Antwi, M., Reddy, V., Waechter, H., Lawler, J., Boss, H., Kurpiel, P. M., Backenson, P. B., et al. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6637a7 · Cited by 45
Melgaço, J. G., Morgado, L. N., Santiago, M. A., de Oliveira, J. M., Lewis‐Ximenez, L. L., Hasselmann, B., Cruz, O. G., Pinto, M. A., & Vitral, C. L. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.06.099 · Cited by 44
Vong, S., Fiore, A. E., Haight, D. O., Li, J., Borgsmiller, N., Kuhnert, W. L., Pinero, F., Boaz, K., Badsgard, T., Mancini, C., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.038 · Cited by 44
Poole, C., & Shakespeare, A. (1993) · BMJ · doi:10.1136/bmj.306.6885.1102 · Cited by 44
Goodman, R. A. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-3-452 · Cited by 44 · cited 1×
“Vaccine safety hypotheses can be generated, but not assessed, through VAERS and are subject to limitations including reporting biases and inconsistent data quality (18,19).”
BackgroundSerologic Studies of Transmission of Hepatitis A in Humans
Decker, R. H., Overby, L. R., Ling, C., Frösner, G., Deinhardt, F. W., & Boggs, J. D. (1979) · The Journal of Infectious Diseases · doi:10.1093/infdis/139.1.74 · Cited by 44
Salleras, L., Bruguera, M., Vidal, J., Plans, P., Domínguez, À., Salleras, M., Navas, E., & Galí, N. (1997) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199706)52:2<215::aid-jmv16>3.0.co;2-j · Cited by 44
Hepatitis A in workers exposed to sewage: a systematic review
Glas, C., Hotz, P., & Steffen, R. J. (2001) · Occupational and Environmental Medicine · doi:10.1136/oem.58.12.762 · Cited by 43
Klein, B. S. (1984) · JAMA · doi:10.1001/jama.1984.03350190018012 · Cited by 43 · cited 8×
“Using HepA vaccine for PEP has advantages over IG, including induction of active immunity, longer duration of protection, ease of administration, and greater acceptability and availability (17).”
BackgroundInfluentialPrevention of hepatitis A by Havrix™: a review
Herck, K. V., & Damme, P. V. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.4.459 · Cited by 42
Single-dose Universal Hepatitis A Immunization in One-year-old Children in Argentina
Urueña, A., González, J. E., Rearte, A., Carrega, M. E. P., Calli, R., Pagani, M. F., Uboldi, A., Vicentín, R., Caglio, P., Cañero-Velasco, M. C., et al. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001322 · Cited by 42
Immunogenicity and Tolerability of Hepatitis A Vaccine in HIV-Infected Children
Gouvêa, A. D. F. T. B., de Moraes‐Pinto, M. I., Ono, É., Dinelli, M. I. S., Machado, D. M., Weckx, L. Y., & Succi, R. C. M. (2005) · Clinical Infectious Diseases · doi:10.1086/432055 · Cited by 40
Dienstag, J. L. (1976) · JAMA · doi:10.1001/jama.236.5.462 · Cited by 40
A waterborne outbreak of hepatitis A in Meade County, Kentucky.
Bergeisen, G. H., Hinds, M. W., & Skaggs, J. W. (1985) · American Journal of Public Health · doi:10.2105/ajph.75.2.161 · Cited by 39
PAPAEVANGELOU, G. J., Roumeliotou‐Karayannis, A. J., & Contoyannis, P. (1981) · Journal of Medical Virology · doi:10.1002/jmv.1890070208 · Cited by 38
Hepatitis A among International Adoptees and Their Contacts
Fischer, G. E., Teshale, E. H., Miller, C., Schumann, C. L., Winter, K., Elson, F., Horan, K., Reed, C., Armstrong, G. L., & Perz, J. F. (2008) · Clinical Infectious Diseases · doi:10.1086/591199 · Cited by 38
Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study
Groom, H. C., Smith, N. X., Irving, S. A., Koppolu, P., Vazquez‐Benitez, G., Kharbanda, E. O., Daley, M. F., Donahue, J. G., Getahun, D., Jackson, L. A., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.043 · Cited by 38
Buxton, J. A., & Kim, J. (2007) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/410362 · Cited by 37
Research works printed but not linked: 22
- Favero MSBW. Disinfection and sterilization. In: Zuckerman AJ TH, ed. Viral hepatitis, scientific basis and clinical management. New York: Churchill Livingstone; 1993. pp. 565–75.
- Nelson N. Hepatitis A. CDC yellow book 2020. New York, NY: Oxford University Press; 2020.
- Knopf-Amelung S. Incarceration and homelessness: a revolving door of risk. In Focus: A Quarterly Research Review of the National Health Care for the Homeless Council 2013;2:5. https://nhchc.org/wp-content/uploads/2019/08/infocus_incarceration_nov2013.pdf
- Safran R. Hepatitis A/B prevention at Washington State Penitentiary. J Investig Med 2010; 58: 242– 3.
- CDC. FDA approval of an alternate dosing schedule for a combined hepatitis A and B vaccine (Twinrix®). MMWR Morb Mortal Wkly Rep 2007; 56: 1057.
- Nelson NP, Link-Gelles R, Hofmeister MG, Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. MMWR Morb Mortal Wkly Rep 2018; 67: 1216– 20. 10.15585/mmwr.mm6743a5 30383742 PMC6319798 · DOI
- Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med [Review]. 2018;8:01. PMC6169986 29500305 · DOI · Paper page
- Mohd Hanafiah K, Jacobsen KH, Wiersma ST. Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr 2011; 10: 57. 10.1186/1476-072X-10-57 22008459 PMC3210090 · DOI
- Nelson NP. Updated dosing instructions for immune globulin (human) GamaSTAN S/D for hepatitis A virus prophylaxis. MMWR Morb Mortal Wkly Rep 2017; 66: 959– 60. 10.15585/mmwr.mm6636a5 28910270 PMC5657912 · DOI
- Nelson NP, Link-Gelles R, Hofmeister MG, Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. MMWR Morb Mortal Wkly Rep 2018; 67: 1216– 20. 10.15585/mmwr.mm6743a5 30383742 PMC6319798 · DOI
- Link-Gelles R, Hofmeister MG, Nelson NP. Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use. Vaccine 2018; 36: 2745– 50. 10.1016/j.vaccine.2018.04.015 29673941 · DOI
- Fiore AE. Hepatitis A transmitted by food. Clin Infect Dis 2004; 38: 705– 15. 10.1086/381671 14986256 · DOI · Paper page
- Staes CJ, Schlenker TL, Risk I, Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics 2000; 106: E54. 10.1542/peds.106.4.e54 11015549 · DOI
- Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992; 10(Suppl 1): S15– 7. 10.1016/0264-410X(92)90533-P 1335649 · DOI · Paper page
- Sharapov UM, Kentenyants K, Groeger J, Roberts H, Holmberg SD, Collier MG. Hepatitis A infections among food handlers in the United States, 1993–2011. Public Health Rep 2016; 131: 26– 9. 10.1177/003335491613100107 26843666 PMC4716468 · DOI
- Morey RJ, Collier MG, Nelson NP. The financial burden of public health responses to hepatitis A cases among food handlers, 2012–2014. Public Health Rep 2017; 132: 443– 7. 10.1177/0033354917710947 28609202 PMC5507430 · DOI
- Ridpath A, Reddy V, Layton M, Hepatitis A cases among food handlers: a local health department response—New York City, 2013. J Public Health Manag Pract 2017; 23: 571– 6. 10.1097/PHH.0000000000000526 28166179 PMC6951794 · DOI
- Hofmeister MG, Foster MA, Montgomery MP, Gupta N. Notes from the field: assessing the role of food handlers in hepatitis A virus transmission—multiple states, 2016–2019. MMWR Morb Mortal Wkly Rep 2020; 69: 636– 7. 10.15585/mmwr.mm6920a4 32437339 · DOI
- Rosenblum LS, Villarino ME, Nainan OV, Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991; 164: 476– 82. 10.1093/infdis/164.3.476 1651359 · DOI · Paper page
- Noble RC, Kane MA, Reeves SA, Roeckel I. Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA 1984; 252: 2711– 5. 10.1001/jama.1984.03350190013011 6492349 · DOI
- Foster MA, Weil LM, Jin S, Transmission of hepatitis A virus through combined liver-small intestine-pancreas transplantation. Emerg Infect Dis 2017; 23: 590– 6. 10.3201/eid2304.161532 28322704 PMC5367420 · DOI
- Klein BS, Michaels JA, Rytel MW, Berg KG, Davis JP. Nosocomial hepatitis A. A multinursery outbreak in Wisconsin. JAMA 1984; 252: 2716– 21. 10.1001/jama.1984.03350190018012 6492350 · DOI
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Surveillance of Vaccination Coverage Among Adult Populations —United States, 2018
Lu, P.-J., Hung, M.-C., Srivastav, A., Grohskopf, L. A., Kobayashi, M., Harris, A. M., Dooling, K. L., Markowitz, L. E., Rodriguez-Lainz, A., & Williams, W. W. (2021) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7003a1 · Cited by 346
Self-citationHepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
Migueres, M., Lhomme, S., & Izopet, J. (2021) · Viruses · doi:10.3390/v13101900 · Cited by 176
“Vaccination has been recommended for MSM and people who use substances for several decades, and people who face homelessness have recently been added to the Advisory Committee on Immunization Practices (ACIP) list [24].”
BackgroundInfluentialZeng, D.-Y., Li, J.-M., Lin, S., Dong, X., You, J., Xing, Q.-Q., Ren, Y., Chen, W.-M., Cai, Y.-Y., Fang, K., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.035 · Cited by 182
EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy
Williamson, C., Nana, M., Poon, L. C., Kupčinskas, L., Painter, R. C., Taliani, G., Heneghan, M. A., Marschall, H., & Beuers, U. H. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.006 · Cited by 182
Metadata
- Authors
- Nelson, N. P., Weng, M. K., Hofmeister, M. G., Moore, K. L., Doshani, M., Kamili, S., Koneru, A., Haber, P., Hagan, L., Romero, J. R., Schillie, S., & Harris, A. M.
- Affiliations
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Vanderbilt University (US)
- Centers for Disease Control and Prevention (US)
- University of Arkansas for Medical Sciences (US)
- Corresponding author
- Nelson, Noele P.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2020-07-03
- Volume
- 69
- Issue
- 5
- Pages
- 1-38
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8631741
- OpenAlex
- W3038438460
- Cited by
- 264
- References
- 302
- Citations by year
- 2026: 35 · 2025: 43 · 2024: 45 · 2023: 52 · 2022: 41 · 2021: 42 · 2020: 5
- FWCI
- 20.57
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- National Center for Immunization and Respiratory Diseases
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis Viruses Studies and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatitis A virus, hepatitis A vaccination, vaccine recommendations, routine childhood immunization, catch-up vaccination, high-risk adults, pre-travel vaccination, post-exposure prophylaxis, anti-HAV IgG, fecal-oral transmission
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Hepatitis A, Humans, Immunization, Infant, United States, Practice Guidelines as Topic, Hepatitis A Vaccines, Advisory Committees
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.